Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Topical Resin Lacquer, Amorolfine, and Oral Terbinafine for Treating Toenail Onychomycosis: a Prospective, Randomized, Controlled, Investigator-blinded, Parallel-group Clinical Trial

NCT01851590 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.

NCT NCT01851590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01851590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Topical Resin Lacquer, Amorolfine, and Oral Terbinafine for Treating Toenail Onychomycosis: a Prospective, Randomized, Controlled, Investigator-blinded, Parallel-group Clinical Trial
Lead sponsor
Helsinki University Central Hospital
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2013
Completion date
October 31, 2014
Enrollment
129 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

onychomycosis